These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 21154750

  • 1. 3,3'-Diindolylmethane enhances taxotere-induced growth inhibition of breast cancer cells through downregulation of FoxM1.
    Ahmad A, Ali S, Wang Z, Ali AS, Sethi S, Sakr WA, Raz A, Rahman KM.
    Int J Cancer; 2011 Oct 01; 129(7):1781-91. PubMed ID: 21154750
    [Abstract] [Full Text] [Related]

  • 2. Inactivation of NF-kappaB by 3,3'-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells.
    Rahman KM, Ali S, Aboukameel A, Sarkar SH, Wang Z, Philip PA, Sakr WA, Raz A.
    Mol Cancer Ther; 2007 Oct 01; 6(10):2757-65. PubMed ID: 17913854
    [Abstract] [Full Text] [Related]

  • 3. 3,3'-Diindolylmethane potentiates paclitaxel-induced antitumor effects on gastric cancer cells through the Akt/FOXM1 signaling cascade.
    Jin H, Park MH, Kim SM.
    Oncol Rep; 2015 Apr 01; 33(4):2031-6. PubMed ID: 25633416
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Plumbagin induces growth inhibition of human glioma cells by downregulating the expression and activity of FOXM1.
    Liu X, Cai W, Niu M, Chong Y, Liu H, Hu W, Wang D, Gao S, Shi Q, Hu J, Zhou X, Yu R.
    J Neurooncol; 2015 Feb 01; 121(3):469-77. PubMed ID: 25528634
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
    Tan X, Fu Y, Chen L, Lee W, Lai Y, Rezaei K, Tabbara S, Latham P, Teal CB, Man YG, Siegel RS, Brem RF, Fu SW.
    Oncotarget; 2016 Jan 05; 7(1):293-307. PubMed ID: 26588055
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression.
    Kwok JM, Myatt SS, Marson CM, Coombes RC, Constantinidou D, Lam EW.
    Mol Cancer Ther; 2008 Jul 05; 7(7):2022-32. PubMed ID: 18645012
    [Abstract] [Full Text] [Related]

  • 16. [Effects of AG1478 on the expression of FOXM1 gene via FOXO3a in non-small cell lung cancer cells].
    Gong XD, Yuan HH, Wang JY, Guo YH, Shi J, Jiang B.
    Zhonghua Zhong Liu Za Zhi; 2013 Aug 05; 35(8):572-8. PubMed ID: 24314213
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxel.
    Li X, Qiu W, Liu B, Yao R, Liu S, Yao Y, Liang J.
    J Transl Med; 2013 Sep 03; 11():204. PubMed ID: 24004449
    [Abstract] [Full Text] [Related]

  • 19. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
    Rahman KW, Li Y, Wang Z, Sarkar SH, Sarkar FH.
    Cancer Res; 2006 May 01; 66(9):4952-60. PubMed ID: 16651453
    [Abstract] [Full Text] [Related]

  • 20. ATM and p53 regulate FOXM1 expression via E2F in breast cancer epirubicin treatment and resistance.
    Millour J, de Olano N, Horimoto Y, Monteiro LJ, Langer JK, Aligue R, Hajji N, Lam EW.
    Mol Cancer Ther; 2011 Jun 01; 10(6):1046-58. PubMed ID: 21518729
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.